Assistant Professor of Small Animal Internal Medicine University of Pennsylvania Philadelphia, Pennsylvania, United States
Presentation Description / Summary: Feline eosinophilic sclerosing fibroplasia (FESF) is becoming increasingly diagnosed in recent years. This session will review current knowledge on this condition, including updated literature and our current understanding of the pathophysiology of this condition with an emphasis on describing the interaction between infectious and inflammatory triggers, clinicopathologic features, disease associations with neoplastic conditions, and tailored treatment options. Finally, gaps in knowledge will be highlighted with discussion of emerging avenues for improving our understanding of this condition, with an emphasis on potential novel therapeutic targets.
Learning Objectives:
1. Describe the infectious and inflammatory triggers that are suspected to lead to FESF
2. Describe the pathophysiology of FESF including key cellular and cytokine players.
3. Define an individualized treatment plan for cases of FESF
4. Describe emerging therapeutic targets for FESF.
